PB2097: ZANUBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE-B CELL LYMPHOMA

Detalles Bibliográficos
Autores principales: Bai, J.-F., Li, J. T., Feng, R., Qian, L., Yin, J., Liu, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431383/
http://dx.doi.org/10.1097/01.HS9.0000851220.50282.7c
_version_ 1784780040445100032
author Bai, J.-F.
Li, J. T.
Feng, R.
Qian, L.
Yin, J.
Liu, H.
author_facet Bai, J.-F.
Li, J. T.
Feng, R.
Qian, L.
Yin, J.
Liu, H.
author_sort Bai, J.-F.
collection PubMed
description
format Online
Article
Text
id pubmed-9431383
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94313832022-08-31 PB2097: ZANUBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE-B CELL LYMPHOMA Bai, J.-F. Li, J. T. Feng, R. Qian, L. Yin, J. Liu, H. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431383/ http://dx.doi.org/10.1097/01.HS9.0000851220.50282.7c Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Bai, J.-F.
Li, J. T.
Feng, R.
Qian, L.
Yin, J.
Liu, H.
PB2097: ZANUBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE-B CELL LYMPHOMA
title PB2097: ZANUBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE-B CELL LYMPHOMA
title_full PB2097: ZANUBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE-B CELL LYMPHOMA
title_fullStr PB2097: ZANUBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE-B CELL LYMPHOMA
title_full_unstemmed PB2097: ZANUBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE-B CELL LYMPHOMA
title_short PB2097: ZANUBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE-B CELL LYMPHOMA
title_sort pb2097: zanubrutinib plus rituximab for the treatment of elderly unfit patients with previously untreated diffuse large-b cell lymphoma
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431383/
http://dx.doi.org/10.1097/01.HS9.0000851220.50282.7c
work_keys_str_mv AT baijf pb2097zanubrutinibplusrituximabforthetreatmentofelderlyunfitpatientswithpreviouslyuntreateddiffuselargebcelllymphoma
AT lijt pb2097zanubrutinibplusrituximabforthetreatmentofelderlyunfitpatientswithpreviouslyuntreateddiffuselargebcelllymphoma
AT fengr pb2097zanubrutinibplusrituximabforthetreatmentofelderlyunfitpatientswithpreviouslyuntreateddiffuselargebcelllymphoma
AT qianl pb2097zanubrutinibplusrituximabforthetreatmentofelderlyunfitpatientswithpreviouslyuntreateddiffuselargebcelllymphoma
AT yinj pb2097zanubrutinibplusrituximabforthetreatmentofelderlyunfitpatientswithpreviouslyuntreateddiffuselargebcelllymphoma
AT liuh pb2097zanubrutinibplusrituximabforthetreatmentofelderlyunfitpatientswithpreviouslyuntreateddiffuselargebcelllymphoma

Ejemplares similares